LABION granted by FRRB – NEVERMIND project

LABION will coordinate the NEVERMIND project!

Starting from 1st January 2020, Dr. Marzia Bedoni will be the PI of a three-years project granted by FRRB to design and test innovative engineered nanovectors to target two brain disorders, Alzheimer’s disease and Glioblastoma.

Project Title.: New frontiers of engineered nanovectors to improve treatment efficacy and safety in neurological disorders - NEVERMIND.

Dr. Bedoni will be supported by the whole LABION team and by the Laboratory of Molecular Medicine and Biotechnology (Coordinated by Dr. Marina Saresella) of Fondazione Don Gnocchi. In the Project Consortium are included also the University of Milano-Bicocca, the University of Milan, Istituto Clinico Humanitas and San Raffaele Hospital.

To learn more about the project, please visit the dedicated page.

schema FRRB_news

No Comments Yet.

Leave a comment